Major Shifts in the Spatio-Temporal Distribution of Lung Antioxidant Enzymes during Influenza Pneumonia by Yamada, Yoshiyuki et al.
Major Shifts in the Spatio-Temporal Distribution of Lung
Antioxidant Enzymes during Influenza Pneumonia
Yoshiyuki Yamada1, Gino V. Limmon1, Dahai Zheng1, Na Li1,2, Liang Li1, Lu Yin1, Vincent T. K. Chow2,
Jianzhu Chen1,3, Bevin P. Engelward1,4*
1 Interdisciplinary Research Group in Infectious Diseases, Singapore-Massachusetts Institute of Technology Alliance in Research and Technology, Singapore, 2Department
of Microbiology, National University of Singapore, Singapore, 3 Koch Institute for Integrative Cancer Research and Department of Biology, Massachusetts Institute of
Technology, Cambridge, Massachusetts, United States of America, 4Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge,
Massachusetts, United States of America
Abstract
With the incessant challenge of exposure to the air we breathe, lung tissue suffers the highest levels of oxygen tension and thus
requires robust antioxidant defenses. Furthermore, following injury or infection, lung tissue faces the additional challenge of
inflammation-induced reactive oxygen and nitrogen species (ROS/RNS). Little is known about the identity or distribution of lung
antioxidant enzymes under normal conditions or during infection-induced inflammation. Using a mouse model of influenza
(H1N1 influenza virus A/PR/8/34 [PR8]) in combination with bioinformatics, we identified seven lung-abundant antioxidant
enzymes: Glutathione peroxidase 3 (Gpx3), Superoxide dismutase 3 (Sod3), Transferrin (Tf), peroxyredoxin6 (Prdx6), glutathione S-
transferase kappa 1 (Gstk1), Catalase (Cat), and Glutathione peroxidase 8 (Gpx8). Interestingly, despite the demand for
antioxidants during inflammation, influenza caused depletion in two key antioxidants: Cat and Prdx6. As Cat is highly expressed
in Clara cells, virus-induced Clara cell loss contributes to the depletion in Cat. Prdx6 is also reduced due to Clara cell loss, however
there is a coincident increase in Prdx6 levels in the alveoli, resulting in only a subtle reduction of Prdx6 overall. Analogously, Gpx3
shifts from the basement membranes underlying the bronchioles and blood vessels to the alveoli, thus maintaining balanced
expression. Taken together, these studies identify key lung antioxidants and reveal their distribution among specific cell types.
Furthermore, results show that influenza depletes key antioxidants, and that in some cases there is coincident increased
expression, consistent with compensatory expression. Given that oxidative stress is known to be a key risk factor during influenza
infection, knowledge about the antioxidant repertoire of lungs, and the spatio-temporal distribution of antioxidants, contributes
to our understanding of the underlying mechanisms of influenza-induced morbidity and mortality.
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Introduction
With its approximately 70 m2 of surface area in direct contact
with the air we breathe, lung tissue needs to have a particularly
robust antioxidant system. Furthermore, during inflammation
reactive oxygen and nitrogen species (ROS/RNS), such as
superoxide, hydrogen peroxide, nitric oxide (NO) and peroxyni-
trite, can cause additional stress by directly or indirectly breaking
covalent bonds in DNA, proteins and lipids [1]. To keep oxidative
and inflammation-driven stress in check, cells exploit both by non-
enzymatic antioxidants, including glutathione and ascorbic acid,
and enzymatic antioxidants, such as superoxide dismutase (Sod),
catalase (Cat), glutathione peroxidase (Gpx) and peroxiredoxin
(Prdx) [2]. While normally these defenses suffice to protect the
lungs against oxidative stress, during infections such as influenza,
there can be a loss of balance between pro-oxidants and
antioxidants, causing potentially lethal conditions [3,4]. Despite
the importance of oxidative stress in disease progression during
influenza, relatively little is known about the identities of the key
antioxidant enzymes in the lung, the cell types in which they are
expressed, or their dynamics following infection.
Superoxide is one of themost abundant ROS, being formed at high
levels by immune cells in response to infection. Superoxide and
hydrogen peroxide (a byproduct of superoxide), are effective toxicants
against invading microbes, but their levels must be kept in check in
order to suppress collateral damage to normal tissues. To defend
normal tissues against superoxide and hydrogen peroxide, several
antioxidant enzymes work in concert. Sod serves to catalyze a rapid
conversion of superoxide into hydrogen peroxide, which is then
detoxified by downstream antioxidant enzymes. There are two types
of intracellular Sod, Cu,Zn-SOD (Sod1) in the cytoplasm and Mn-
SOD (Sod2) in themitochondrion. In addition, high levels of EC-SOD
(Sod3) are located on the external surfaces [5]. Hydrogen peroxide is
then decomposed into H2O by downstream antioxidant enzymes,
including Cat, Gpx, Prdx and many other peroxidases [2]. It is there-
fore the coordinated action of these enzymatic antioxidant enzymes
that is necessary in order to assure maintenance of a balance between
pro-oxidants and antioxidants, thus preventing oxidative stress.
During influenza-induced inflammation, immune cells produce
superoxide and NO by activation of xanthine oxidase and inducible
nitric oxide synthase (iNOS) as antimicrobial responses. The resulting
high levels of reactive oxygen and nitrogen species lead to a reduction
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in the levels of ascorbic acid and reduced glutathione [3,6]. In
response, enzymatic defenses including heme oxygenase 1 (Hmox1),
Gpx1, and thioredoxin reductase 1 can be induced during influenza
infection [7,8]. Nevertheless, pro-oxidants as well as antioxidants are
needed, since elevated levels of NO-producing macrophages and
dendritic cells ultimately help to control morbidity and mortality
associated with highly pathogenic influenza A viruses [4].
Influenza-induced oxidative stress can lead to catastrophic loss of
cell and tissue function. As little is known about that spatio-temporal
distribution of antioxidants, here, we identified and traced the levels of
the major lung antioxidants through the course of disease. Intere-
stingly, we observe that antioxidant levels not only rise for some
enzymes and fall for others, but furthermore there are significant shifts
in the regions and cell types in which they are expressed. Indeed, for
two antioxidants, viral-induced depletion in one cell type is associated
with increased expression in another, suggesting compensatory expre-
ssion. Given that appropriate antioxidant responses govern cell surv-
ival, knowledge of the coordinated action of antioxidant enzymes con-
tributes to our understanding of disease susceptibility and progression.
Results
Bioinformatic analysis reveals the spectrum of
antioxidants expressed at high levels in lung cells,
immune cells, and stem cells
Our first objective was to identify lung-abundant, and possibly
lung-specific, antioxidant enzymes. We therefore carried out a
bioinformatics analysis of published mouse gene expression data
(GNF Mouse GeneAtlas V3, GSE10246, [9]) using Gene Spring
GX software (Agilent Technologies). Gene expression of 34
antioxidant enzymes (Table 1) that are present in the lung were
compared to non-lung samples, which includes 90 different
organs, tissues and cells. Antioxidants with more than a 5-fold
increase in the lung relative to non-lung samples were classified to
be lung-abundant. Although there was no antioxidant proteins
exclusively expressed in the lung, we nevertheless identified seven
key lung-abundant antioxidant enzymes: Gpx3 (35.97-fold), Sod3
(32.04), transferrin (Tf, 17.58), Prdx6 (11.39), glutathione S-
transferase kappa 1 (Gstk1, 6.55), Cat (6.06) and Gpx8 (5.88)
(Table 1). Identification of lung-abundant antioxidants enables
more detailed studies of their spatio-temporal distribution
following infection.
A complicating factor when studying the prevalence of different
antioxidant enzymes is the potential contribution of antioxidants
present within infiltrated immune cells and progenitors during
inflammation and tissue repair, respectively. We therefore assessed
expression of antioxidant genes in key immune cells, including
macrophages, granulocytes, dendritic cells, NK cells, B cells, T
cells, thymocytes and mast cells, as well as progenitors and stem
cells. We found that immune cells, progenitors, and stem cells
express lower levels of the lung-abundant antioxidant transcripts
than lung tissue. For example, the range of expression was: Gpx3
(210.42 to 22.02 fold, except for 3.33 in bone marrow), Sod3
(23.52 to 21.68) and Tf (214.35 to 3.79, except for 4.55 in bone
Table 1. Summary of lung-, immune cell- and stem cell-abundant antioxidants elucidated from published gene expression data
GSE10246.
Abundant in Gene* Probe ID Fold increase** Subcellular localization***
Symbol Entrez ID
Lung Gpx3 14778 1449106_at 35.97 EC, PL
Sod3 20657 1417633_at 32.04 EC, PL
Tf 22041 1425546_a_at 17.58 EC, PL
Prdx6 11758 1423223_a_at 11.39 Cyt, Lys, Cv
Gstk1 76263 1452823_at 6.55 Mit
Cat 12359 1416430_at 6.06 Per
Gpx8 69590 1424099_at 5.88 Mem
Immune cells
LPS-activated macrophage Hmox1 15368 1448239_at 114.74 (24hrs post activation) ER, Mic
(Bone marrow) Ptgs2 19225 1417262_at 154.01 (6 hrs post activation) Mem
Sod2 20656 1417193_at 11.91 (6 hrs post activation) Mit
Mast cells Ptgs1 19224 1436448_a_at 75.01 (+IgE) Mem
Stem cells & Progenitors
Granurocytes Mpo 17523 1415960_at 363.11 (Progenitors) Lys
Dendritic cells Ptgs2 19225 1417262_at 18.83 (CD8-) Mem
Bone marrow Mpo 17523 1415960_at 299.11 Lys
Epx 13861 1449136_at 67.44 Cyt
Common myeloid progenitors Mpo 17523 1415960_at 203.73 Lys
Stem cells HSC Mpo 17523 1415960_at 75.96 Lys
Emryonic stem cell line V26 Ptgs2 19225 1417262_at 11.81 Mem
*Antioxidant genes that are not abundant in the above tissue and cells: Duox1, Gpx1, Gpx2, Gpx4, Gpx5, Gpx6, Gpx7, Gsr, Lpo, Prdx1, Prdx2, Prdx3, Prdx4, Prdx5, Prdx6-
rs1,Sod1, Srxn1, Tpo, Txnrd1, Txnrd2, Txnrd3.
**Fold increase against the base line of all other tissues and cells in GSE10246.
***Abbreviations: Cyt, cytoplasm; Cv, cytoplasmic vesicle; EC, extracellular; ER, endoplasmic reticulum; Lys, lysosome; Mit, mitochondrion matrix; Mem, membrane; Per,
peroxisome; PL, plasma.
doi:10.1371/journal.pone.0031494.t001
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marrow). These findings suggest that analysis of the seven lung-
abundant antioxidant enzymes during influenza infection will
reveal predominantly expression in somatic lung tissue.
Although analysis of normal immune cells did not reveal high
levels of expression of lung-abundant antioxidants, it was also
possible that cytokines and chemokines present during inflamma-
tion might cause macrophages, and other immune cells, to induce
antioxidants. Indeed, further analysis of previously published
microarray data revealed that some antioxidants, especially
prostaglandin-endoperoxide synthase 2 (Ptgs2) and Hmox1, are
transiently-expressed at very high levels in LPS-activated bone
marrow macrophages with the peaks at 6 and 24 h post-activation,
respectively (Table 1). Additionally, we found that myeloperoxi-
dase (Mpo) is expressed at high levels in neutrophil progenitors. In
contrast, all other differentiated immune cells, progenitors and
stem cells express antioxidants at baseline or lower levels
compared to lung tissue. Therefore, while there are several
noteworthy examples of antioxidants induced in immune cells, the
seven lung-abundant antioxidant enzymes are clearly enriched in
normal lung tissue.
Animal model for H1N1 infection
To study influenza in an animal infection model, mice were
infected with a sublethal dose of H1N1 influenza virus A/PR/8/
34 (PR8) and monitored over the course of several weeks. Key
markers of infection included weight loss, viral load and expression
of tumor necrosis factor (Tnf). Influenza-infected animals experi-
enced significant weight loss starting about 5 days after infection,
and animals reached their lowest weights at about 10 to 11 dpi,
after which, body weights recovered gradually (Fig. 1A). To
monitor viral proliferation, expression of influenza nucleoprotein
(NP) mRNA was investigated. Viral abundance rose quickly
between 1 and 5 dpi and then slowly declines, virtually
disappearing by day 13 (Fig. 1B). We also observed an increase
in the levels of Tnf, a pro-inflammatory cytokine produced
following virus infection with a peak between 5–7 dpi (which is
consistent with previous studies [10], Fig. 1B).
Kinetics of lung-abundant antioxidants following PR8
infection
To learn about the spatio-temporal dynamics of the seven lung-
abundant antioxidants during the course of influenza infection, we
first quantified transcript levels via real time RT-PCR (qRT-PCR).
Despite the increased demand for antioxidant activity during
inflammation, we observed a marked decrease in transcript levels at
7 dpi (immediately after the peak of viral load) for all lung-abundant
antioxidants, except for Gpx3 (Fig. 2A, blue box). In contrast, for
antioxidants induced in immune cells (red box, Fig. 2A), we
observed increased levels of transcripts. Specifically, at 5 dpi (Ptgs2)
and 13 dpi (Hmox1) increase, which is consistent with an increase in
the macrophage marker, EGF-like module containing, mucin-like,
hormone receptor-like 1 (Emr1), (Fig. 2A in red box).
Of particular interest is the observation that antioxidant levels are
apparently reduced during infection. To learn if there is also
suppression of lung-abundant antioxidants at the protein level, we
performed immunoblotting. Initial analysis of viral burden shows
that the influenza integral membrane protein M2 protein was
detectable 3–9 dpi, peaking on 5 dpi (Fig. 2B and supporting figure
S1). Analysis of two of the lung-abundant antioxidants, Cat and
Prdx6, revealed a decrease in protein levels (between 7 and 15 dpi),
which is consistent with the results for the transcript levels. However,
a more subtle reduction was observed for Prdx6 (Fig. 2B and S1). In
contrast, extracellular lung-abundant Gpx3 and Tf (but not Sod3),
were significantly increased, although transcript levels were not
(Fig. 2A). Finally, consistent with the presence of influenza-induced
inflammation, the levels of Hmox1 (abundant in LPS-activated
macrophage) also increased with a peak at 13 dpi, that is consistent
with the observed increase in transcript levels (Fig. 2B and S1).
Clara and AT2 cells are the major PR8-permissive cell
types in mouse lung
One possible explanation for the reduction in Cat and Prdx6 is
that cells that normally express these antioxidants are cleared due
to viral infection. To visualize how viral infection spread within the
mouse lungs, we first immunostained lung sections with antibodies
against viral-nonstructural protein 1 (NS1). Antibody against Clara
cell secretory protein (CCSP) was used to distinguish bronchioles
from alveoli. We observed that some bronchial cells are NS1-
positive at 1 dpi (arrows in Fig. 3A b) and that the majority of
Figure 1. Animal model for H1N1 infection. Mice were infected
with sub-lethal dose of PR8 by intra-tracheal inhalation. A. Influenza-
induced weight loss of the infected mice started from 4 dpi, reached to
the peak at 10 and 11 dpi, after which, body weight recovered
gradually. Body weights of all infected mice were measured daily. Data
of individual mouse and an average of each time point were plotted
with rhombus and line, respectively. B. mRNA of influenza nucleopro-
tein (NP) in the lung tissue reached to a maximum at 5 dpi, and
decreased by 13 dpi. In contrast, tumor necrosis factor (TNF) expression
was the highest around 5–7 dpi. mRNA expression in the lung tissue
was investigated by qRT-PCR. Beta-actin was used for normalization.
doi:10.1371/journal.pone.0031494.g001
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lungs are normal. At 3 dpi, viral replication sites spread to most of
the bronchial cells and also to several alveolar regions (c).
Subsequently, NS1-positive cells were mainly observed in the
alveoli (d, e) with a peak at 5 dpi and drastically reduced by 9 dpi
(f). These data are in agreement with expression kinetics of NP
mRNA (Fig. 1B) and M2 protein (Fig. 2B and S1).
To reveal which cell types are most susceptible to the PR8
infection, we further immunostained tissue sections with antibodies
that are specific for the two pneumocytes: alveolar epithelial type 1
(AT1) cells (podoplanin; Pdpn, Fig. 3B c) and alveolar epithelial
type 2 (AT2) cells (surfactant protein C; SPC, Fig. 3B b). Analysis
of lung tissue on 1 dpi revealed the presence of NS1 protein in
bronchial Clara cells (Fig. 3B d, e, f). Virus-infected Clara cells did
not change CCSP expression at this timing. The infected Clara
cell layer was subsequently destroyed by the virus (Fig. 3B g, h, i)
and the virus appears to then spread to cells to the alveoli (Fig. 3A
c). At 5 dpi, infected cells co-stained with NS1 and a marker for
AT2 cells (SPC; white arrows in j, k, l), indicating that AT2 cells
are infected after Clara cells. The widespread disappearance of the
AT2 marker indicates that Clara cells are cleared by the virus
(Fig. 3B j). In contrast to Clara and AT2 cells, we observed
relatively few virus-infected AT1 cells (white arrows in m, n, o) at
7 dpi. Taken together, viral infection primarily leads to rapid
clearance of Clara cells, followed by infection and destruction of
AT2 cells, which is consistent with previous studies [11].
To learn more about cell-level dynamics, we assessed the relative
abundance of key lung cell types using qRT-PCR. In addition to
quantifying transcripts specific for Clara, AT2 and AT1 (e.g.,
CCSP, SPC and Pdpn), thyroid transcription factor-1 (TTF-1) was
analyzed, as it is specifically highly expressed in both Clara and AT2
cells in the mouse lung [12], and it regulates CCSP and SPC
expression [13,14]. As shown in Fig. 3C, mRNA of CCSP, SPC and
TTF-1 (Clara and AT2 cells) were all significantly reduced during
the course of infection, which is consistent with the data showing
viral clearance of Clara and AT2 cells. In contrast, there was no
significant change in Pdpn (AT1 cells), as expected given the low
level of infection of AT1 cells. Consistent with the transcript levels,
immunoblotting shows a dramatic decline in the protein levels of
key Clara and AT2 cell markers (CCSP and TTF-1 [SPC was not
included because they detected as multiple cleaved bands]), but not
for AT1 cells (Pdpn), (Fig. 3D and S1). Taken together, Clara and
AT2 cells, which harbor the greatest viral load, are also the most
depleted from the infected lungs.
Lung-abundant Cat and Prdx6 are strongly expressed by
Clara and AT2 cells in the mouse lung
To test the possibility that depletion of PR8-permissive cells
leads to a change in antioxidant levels, we set out to identify
antioxidants that are differentially expressed in Clara and AT2
cells by immunohistochemistry. Cat was strongly detected in Clara
cells, with some expression in arterial blood vessels and cells
scattered around the alveoli (Fig. 4A a, b, c). Cat was also highly
expressed in AT2 cells in alveoli (positive for SPC; Fig. 4A d, e, f).
Thus, Cat expression is highest in the two cell types that are most
susceptible to viral infection. On the other hand, Prdx6 levels were
extremely high in Clara cells and detected in both nucleus and
cytoplasm (Fig. 4B a, b, c), whereas expression in AT1 (Pdpn
positive) alveolar cells was largely diffuse (thick arrows in d, e, f).
We also observed Prdx6-positive nuclei in the alveoli that could
potentially be nuclei of AT1 cells (thin arrows in g, h, i and S2A).
In rat, lung Prdx6 are strongly expressed in Clara (except for
major bronchi) and AT2 cells in the tissue sections and in the
cytoplasm of freshly isolated AT2 and alveolar macrophages [15].
However, cells with Prdx6-positive nucleus were not co-stained
with SPC in mice (AT2 cells, g, h, i). We also observed that CD68-
positive macrophages are scattering in the normal alveoli and
sometime at bronchiole (frozen sections were stained with CD68
antibody [Abcam ab53444], Data not shown), however, we unable
to detect macrophage like cells which are Prdx6-positive in both
nucleus and cytoplasm. Overall, these data show that both Clara
and AT2 cells express high levels of Cat, and Clara cells express
high levels of Prdx6, such that viral destruction of Clara and AT2
cells is expected to reduce the reserves of these two important
antioxidants, which was indeed observed (Fig. 2B).
Loss of Prdx6-expressing Clara cells coincides with
induction of Prdx6 in AT1 cells
Despite the high levels of Prdx6 expression in Clara cells and
their subsequent virus-induced clearance, we observed only a
slight reduction in the overall levels of Prdx6 (Fig. 2B). To address
the question as to why a large change in Clara cell abundance did
not result in a coincident large change in the overall levels of
Prdx6, we monitored the levels of Prdx6 by immunostaining over
the course of the infection. Surprisingly, our staining demonstrated
that Prdx6 expression in the lungs is indeed drastically changed
following the influenza infection (Fig. 5A). At 1 dpi, there was no
change in Prdx6 and CCSP expression in NS1-positive Clara cells
(Fig. 5B d, e, f), which suggests that influenza replication does not
directly impact the expression of these proteins. Subsequently,
however, there was a significant loss of Clara cells (see FIg. 3A),
and with a concomitant reduction in staining for bronchial Prdx6
(Fig. 5A c, d and 5B g, h, i, j, k, l). Regeneration of a layer of Clara
cells was relatively fast, and the expression level of bronchial
CCSP and Prdx6 started to recover after 9 dpi (Fig. 5A f, g, 5B m,
n, o and S2B).
In contrast to Clara cells, a very different picture emerges for
the alveolar spaces. As in un-infected mice (5A a and 5C a, b, c),
Prdx6 was weakly detected in the alveolar spaces at 1 dpi (5A b).
However, by 5 dpi, there is a significant increase in the overall
levels of Prdx6 expression (5A d and 5C d, e, f). Expression of
alveolar Prdx6 reached to the peak at 7 dpi (5A e and 5C g, h, i)
and diffused at 9 dpi (5A f and 5C j, k, l). Given that Prdx6 exactly
co-localized with Pdpn (Fig. 6 a, b, c), it appears that AT1 cells
account for a possible compensatory induction of Prdx6.
Interestingly, strong induction of Prdx6 in AT1 cells is a transient
event and AT1 cells in the inflamed alveoli were depleted after
9 dpi (Fig. 6 d, e, f, and S2B). At 11 dpi, Prdx6 in heavily inflamed
alveoli totally disappeared, but the marked regeneration of Prdx6
was observed in the bronchioles (Fig. 5A g). As we did not observe
Prdx6-positive nuclei in the area where Pdpn (AT1 cells) were
Figure 2. Kinetics of lung-abundant antioxidants following PR8 infection. Mice were infected with sub-lethal dose of PR8 by intra-tracheal
inhalation. A. Influenza-induced change of transcript levels of the seven lung-abundant antioxidants (in blue box), macrophage cell marker (Emr1 in
red box) and activated macrophage-abundant antioxidants (in red box) in the lung tissue was investigated by qRT-PCR. Beta-actin was used for
normalization. B. PR8 infection reduced lung-abundant Cat and Prdx6, while lung-abundant plasma antioxidants were increased (Gpx3 and Tf) or
consistent (Sod3) over the course of infection. Activated macrophage-abundant Hmox1 increased following the clearance of viruses. Lung protein
extracts from three mice were pooled, separated by SDS-PAGE and labeled with the indicated antibodies.
doi:10.1371/journal.pone.0031494.g002
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depleted (Fig. S2B), Prdx6 is generally expressed by Clara and
AT1 cells in the mouse lungs. Unlike Prdx6, Cat was not induced
in AT1 cells (see Fig. 7 f, g, h), which is consistent with the
observation of an overall decline in Cat. Together, these data
reveal a balancing act wherein Prdx6-expressing Clara cell loss is
followed by an increase in Prdx6 in alveolar AT1 cells, thus
minimizing the overall loss of Prdx6.
Lung Gpx3 shifts from the basement membrane to
alveoli following infection
In healthy mouse lungs, we observed that Gpx3 accumulates at
the basement membranes that underlie blood vessels and
bronchioles (which is consistent with previous studies [16]; Fig. 7
a and S3A). Additionally, we found a weak association of Gpx3
with other cell types, including AT2 cells, creating a fairly uniform
distribution on the surface of alveoli (Fig. 7 e and S3A). These data
are consistent with a model wherein Gpx3 is normally secreted
from AT2 cells (and other cell types) and targets basement
membranes or cell surfaces.
Following influenza infection, Gpx3 became diffuse by 5–7 dpi
(Fig. 7 b, c). Ultimately, as tissue recovered from influenza
infection, Gpx3 started to accumulate again at the basement
membranes 9 dpi (d). In contrast to the observed drop in basement
membrane associated Gpx3 during viral replication period (5–
7 dpi), the levels of alveolar Gpx3 gradually increased following
infection (Fig. 7 e, f, g, h). Alveolar Gpx3 rarely co-localized with
Prdx6 in AT1 cells (thick arrows in Fig. S3B a, b, c), showing that
Gpx3 is not bound uniformly to the surface of alveolar cells. Note
that we also observed the presence of intracellular Gpx3 within
infiltrated cells, but the specific cell type is not known (thin arrows
in Fig. S3B a, b, c). Thus, there is a significant shift in the
localization of Gpx3, from basement membranes to alveolar
spaces, which is consistent with compensatory expression and/or
movement of plasma. Together with Prdx6, these are two
independent examples in which a drop in antioxidants in one
cell type (either because of cell loss or because of changes in
affinity) is associated with an increase in the same antioxidant in
another location.
Discussion
It is widely recognized that imbalances in the lung antioxidant
system can lead to oxidative stress, which in its most severe form,
potentiates influenza-induced morbidity and even mortality [3].
Nevertheless, remarkably little is known about the nature of
antioxidant enzymes that are most prevalent in the lung, or about
how infection impacts the levels of antioxidant enzymes. Based
upon published expression profiles, we have identified seven
antioxidant proteins that are particularly abundant in the lung and
we have traced their spatio-temporal profiles during the course of
infection. Interestingly, we observed dramatic shifts in the levels of
antioxidants during infection, and we found that some of the most
significant changes are due to loss of influenza virus permissive
cells, including bronchial Clara cells and alveolar AT2 cells.
To learn about the roles of Clara and AT2 cells in modulating
the levels of antioxidant enzymes, we used immunohistochemistry
to analyze the antioxidant expression in these cells. Among the 7
key lung-abundant antioxidant enzymes, Clara cells strongly
express two intracellular antioxidants, Cat and Prdx6. Clara cells
have several functions, one of which is to protect bronchioles by
providing a lining of cells and by secreting a variety of proteins,
including CCSP and surfactant A (SPA) [17]. In addition, Clara
cells also able to break down harmful substances inhaled into the
lungs and to detoxify them in smooth endoplasmic reticulum via
cytochrome P450 enzymes, which generate ROS [18,19]. It is thus
reasonable to conjecture that high levels of intracellular antiox-
idant enzymes protect Clara cells against ROS stress that results
both from a high oxygen tension and from Clara cell-specific
cytochrome P450 enzymes.
Although Prdx6 is robustly expressed in Clara cells and Clara
cells become depleted, the overall levels of Prdx6 stay relatively
constant. Analysis of the dynamics of Prdx6 during disease
progression shows that the levels of Prdx6 rise significantly within
the alveolar spaces. These data are consistent with antioxidant
rebalancing, or compensatory expression. This response is not
driven by viral replication, since Prdx6 induction was observed in
both infected and uninfected cells. Importantly, Prdx6 levels rise in
AT1 cells, which cover more than 95% of the surface of alveoli
and account for gas exchange [20]. Therefore, even a relatively
small increase in the levels of Prdx6 when analyzed by
immunohistochemistry, can lead to a significant overall increase
in the levels of Prdx6 in the lung, thus compensating for the drop
in Prdx6 due to the loss of Clara cells. Rat AT1 is known to act not
only as a barrier for gas exchange but also as a barrier to oxidative
injury via secretion of apolipoprotein E and Tf [21]. Likewise,
induction of Prdx6 in mouse AT1 cells may also provide a critical
defense against infection-induced oxidative stress.
Prdx6 is a unique bifunctional enzyme with GSH peroxidase
activity (which reduces hydrogen peroxide and phospholipid
hydroperoxide to oxidized glutathione and water) and phospholi-
pase A2 (PLA2) activity, whose products signal a pro-inflammatory
response [22,23]. Its lipid peroxidation-reducing activity enables the
resolution of oxidized lipids in the cell membrane, which would
otherwise have the capacity to amplify damage through a chain
reaction of oxidation and lipid breakdown products. Therefore,
Prdx6 has direct protective effect against toxicity and apoptosis [24].
Interestingly, Prdx6 demonstrates lung-specific functions via the
interaction with SPA that translocates Prdx6 into lamellar body and
extracellular space [25]. In addition, SPA regulates PLA2 activity of
Prdx6 and alters its ability to degrade the major phospholipid of
Figure 3. Clara and AT2, but not AT1 cells, are the major PR8-permissive cell types in mouse lung. Mice were infected with sub-lethal
dose of PR8 by intra-tracheal inhalation. A. PR8 replication sites (viral nonstructural protein 1 [NS1]-positive cells) spread from bronchial cells to
alveoli with the peak at 5 dpi and almost completely disappeared by 9 dpi. Lung sections were immunostained with CCSP, NS1 and Prdx6. Slides
were scanned by MIRAX MIDI system with the exact same exposure times for DAPI, CCSP, Prdx6 and NS1, respectively, and images were shown with
the same adjustment of brightness and contrast. Scanned image for Prdx6 was shown in Fig. 5A. The scale bars represent 500 mm. Infected cells at
1 dpi were pointed with arrows. B. NS1 was mainly detected in bronchial (Br) Clara cells at 1 dpi (d, e, f), and then a layer of infected Clara cells lysed
at 3 dpi (g, h, i). Alveolar infected cells at 5 dpi were co-stained with SPC (white arrows in j, k, l). NS1-positive AT1 cells (white arrows in m, n, o) were
sometimes observed at mildly inflamed area at 7 dpi. Lung sections were immunostained with the indicated antibodies and observed at 660
magnification with confocal microscope. The scale bars represent 50 mm. C. Gene expression of CCSP, SPC and TTF-1, but not Pdpn, was reduced
following infection. mRNA expression in the lung tissue was investigated by qRT-PCR. Beta-actin was used for normalization. D. PR8 infection reduced
protein levels of CCSP and TTF-1, but not Pdpn. Lung protein extracts from three mice were pooled, and were subjected to immunoblotting analysis
with the indicated antibodies.
doi:10.1371/journal.pone.0031494.g003
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surfactant [25,26]. Finally, PLA2 activity of Prdx6 also plays a
critical role in oxidative stress- and TNF-induced apoptosis [27].
Further studies on the mechanism of Prdx6 induction in AT1 cells
and its potential role in suppressing influenza-induced apoptotic cell
death are in progress.
After infecting Clara cells, the virus moves deeper into the lung
and replicates in AT2 cells, which are found in the alveoli. AT2 cells
are known as secretory cells which release the components of
surfactant and extracellular matrix [28] and extracelluar antioxi-
dants Gpx3 and Sod3 [16,29]. These observations are consistent
with a role for AT2 cells in providing antioxidant protection to cells
coated with AT2-produced surfactant (e.g., AT1 cells). Thus, AT2
cells represent another target cell type that, when virally infected,
might lead to loss of extracellular antioxidant enzymes. Unexpect-
edly, however, we did not observe any effects of AT2 cell depletion
on antioxidant protein expression levels in the lungs. In particular,
GPX3 was increased at the time of drastic loss of AT2 cells.
Although both Sod3 and Gpx3 are secreted by AT2 cells in the
lungs, they are also secreted by kidney proximal tubule cells [30,31].
Immunostained lung sections demonstrated that Gpx3, which is
normally at the basement membrane of blood vessels, becomes
diffuse and is subsequently increased throughout the alveolar spaces.
Therefore, it is possible that plasma Gpx3 gains access to the lungs
due to increased permeability during infection. Thus, the reduction
in AT2-secreted Gpx3 is likely masked by the influx of antioxidants
in the plasma, thus providing alternative mechanism for maintain-
ing the balance of antioxidants during infection.
In summary, here we have identified novel lung-abundant
antioxidant enzymes and we have shown that influenza virus
infection impacts their spatio-temporal distribution. Both Clara
and AT2 cells are the major influenza-permissive cell types in the
lungs, and their loss lead to reduction of key lung antioxidants.
However, we present two examples wherein loss of expression of
antioxidants is balanced by expression by other cell types.
Specifically, both the Clara-enriched Prdx6 and the AT2-enriched
Gpx3 are maintained, possibly by compensatory expression system
during infection. Taken together, this work reveals several novel
lung-specific antioxidants and new mechanisms by which the lungs
maintain their levels of antioxidants during infection. Influenza
toxicity can be caused by oxidative stress, which can be
exacerbated by imbalances in the levels of lung-abundant
antioxidants. A deeper understanding of the biology and the
responses of lung-abundant antioxidants to influenza is therefore
fundamental to our understanding of influenza-induced morbidity
and mortality.
Materials and Methods
Mice and virus
The H1N1 influenza virus A/PR/8/34 strain (PR8) was
purchased from American Type Culture Collection (ATCC).
PR8 was propagated in embryonated chicken egg at 37uC for
72 h, and the allantoic fluid was harvested as a viral stock. Virus
titers were determined by the plaque assay via infection of Madin-
Darby Canine Kidney (MDCK) cells. Ten to twelve weeks old
female C57/BL6 mice were housed in BSL2 facilities, and infected
with sub-lethal dose of PR8 (30 PFU in 75 ml of phosphate
buffered saline [pH 7.4] per mouse) by intra-tracheal inhalation
after anesthetization. Lungs were harvested from anesthetized
mice at indicated time points and stored at 280uC until use.
Infected mice did not recover completely at the end of our
experiments (17 dpi) as we observed some infiltrated area in the
lung sections (Data not shown).
Ethics Statement
This study was carried out in strict accordance with the with the
National Advisory Committee for laboratory Animal Research
(NACLAR) Guidelines (Guidelines on the Care and Use of
Animals for Scientific Purposes) in facilities licensed by the Agri-
Food and Veterinary Authority of Singapore (AVA), the
regulatory body of the Singapore Animals and Birds Act. The
protocol was approved by the Institutional Animal Care and Use
Committee (IACUC), National University of Singapore (Permit
Number: IACUC 117/10).
Antiobodies
Primary antibodies used in this study were shown in supporting
table S1. Secondary antibodies were purchased from the following
sources: horseradish peroxidase (HRP)-conjugated anti-goat, -
mouse and -rabbit secondary antibodies from DAKO; Alexa Fluor
488-, 546 or 647-labeled anti-goat, -mouse, -rabbit and -rat
secondary antibodies from Invitrogen.
Quantitative real-time RT-PCR
Total RNA was extracted by using Qiagen RNeasy mini kit and
treated with DNaseI (Qiagen). RNA concentration was measured
by the ND-1000 spectrophotometer (NanoDrop Technologies)
and 1 mg of RNA were reverse-transcribed by using oligo(dT) and
iScript reverse transcriptase (Bio-rad). PCR was performed with
the Bio-Rad CFX-96 real-time system using Ssofast Evagreen
Supermix according to the manufacturer’s instructions (Bio-Rad).
Primers used in this study were listed in supporting information
(Table S2). Previously reported primer sequences were obtained
from PrimerBank (http://pga.mgh.harvard.edu/primerbank/in-
dex.html) and a literature [32]. PCR was carried out for 95uC for
30 s, 40 cycles at 95uC for 1 s and 60uC for 10 s. Data were
normalized with beta actin. Trends of the changes in gene
expression were confirmed by the two independent experiments.
Immunoblotting
Lungs were lysed with 26 Laemmli sample buffer without
bromophenol blue and the protein concentration was determined
by the Bio-rad Protein Assay kit. Five mg of protein (10 mg for
Hmox1) were separated by SDS-PAGE and transferred to
nitrocellulose membranes (Bio-rad). Membranes were incubated
with a primary antibody for overnight at 4uC, subsequently with
HRP-conjugated secondary antibody for 1 h at room temperature,
and detected using the enhanced chemiluminescence (ECL) prime
Figure 4. Lung-abundant Cat and Prdx6 are strongly expressed by Clara and AT2 cells in the mouse lung. Lung sections from
uninfected mice were immunostained with the indicated antibodies and observed at660 magnification with confocal microscope. The scale bars
represent 50 mm. Abbreviation: Br; bronchioles, Bv; blood vessels. A. Cat was strongly expressed in Clara cells, arterial blood vessels and cells
scattered in alveoli (a, b, c). Cells with higher Cat expression at alveoli were co-stained with SPC (d, e, f). B. Prdx6 expression was extremely high in
bronchial Clara cells (a, b, c). Alveolar Prdx6 was detected in AT1 cells (thick arrows in d, e, f), unknown cell types with Prdx6-positive nuclei (thin
arrows in g, h, i) or weakly in AT2 cells (thick arrows in g, h, i). Different exposure settings for image capturing were used for Prdx6 here
(Corresponding Prdx6-positive nuclei were circled with dashed line in b, e, h).
doi:10.1371/journal.pone.0031494.g004
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Figure 5. Loss of Prdx6-expressing Clara cells coincides with induction of alveolar Prdx6. Lung sections were immunostained with CCSP,
NS1 and Prdx6 antibodies. Slides were scanned by MIRAX MIDI system with the exact same exposure times for DAPI, CCSP, Prdx6 and NS1,
respectively, and images were shown either with the same adjustment of brightness and contrast (A) or without any adjustments (B, C). The scale
bars represent 500 mm (A) or 50 mm (B, C), respectively. A. Loss of bronchial Prdx6 coincides with induction of alveolar Prdx6 in the mouse lungs
following influenza infection. Scanned image for CCSP and NS1 were shown in Fig. 3A. B. Prdx6 in CCSP-positive bronchial (Br) Clara cells drastically
decreased following infection (a to l), but started to regenerate at 9 dpi (m, n, o). C. Alveolar Prdx6 was increased when many Clara cells were
depleted from the lung at 5 dpi (d, e, f), and was strongly expressed at 7 dpi (g, h, i). Prdx6 was then diffused at heavily inflamed area of the alveoli (j,
k, l).
doi:10.1371/journal.pone.0031494.g005
Figure 6. AT1 cells account for a possible compensatory induction of Prdx6. Pdpn and alveolar Prdx6 were exactly co-localized at 7 dpi (a,
b, c). Pdpn and Prdx6 were both depleted at heavily inflamed alveoli at 9 dpi (d, e, f). White arrows indicate cells with Prdx6-positive nucleus.
Immunostained slides were observed at660 magnification in the confocal microscope. The scale bars represent 50 mm.
doi:10.1371/journal.pone.0031494.g006
Figure 7. Lung Gpx3 shift from the basement membrane to the alveolar space following infection. Gpx3 at basement membrane of
blood vessels (Bv) and bronchioles (Br) was totally diffused at 5 and 7 dpi (a, b, c), but started to accumulate again at 9 dpi (d). In contrast, Gpx3
gradually increased and accumulated in the alveolar spaces (e, f, g, h). Mice were infected with sub-lethal dose of PR8 by intra-tracheal inhalation.
Lung sections from uninfected mice were immunostained with the indicated antibodies and observed at 660 magnification with confocal
microscope. The scale bars represent 50 mm.
doi:10.1371/journal.pone.0031494.g007
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detection reagents (GE healthcare). Trends of the changes in protein
expression were confirmed by the two independent experiments.
Immunofluorescent staining of paraffin sections
Lungs harvested from anesthetized mice were fixed in 10%
neutral buffered formalin solution (Sigma Aldrich) overnight,
followed by embedding in paraffin with tissue processor (Leica).
Five mm sections on poly-L-lysine coated slides (Thermal
Scientific) were de-waxed with xylene and rehydrated in water.
Antigen retrieval was processed with proteinase K (Sigma Aldrich,
20 mg/ml in 50 mM Tris-HCl, 1 mM EDTA, pH 8.0) at 37uC
for 30 min. The sections were incubated with appropriate
antibody overnight at 4uC, and stained with secondary antibody
for 1 h at room temperature. The slides were mounted with anti-
fade reagent with DAPI (Invitrogen) and then scanned by high-
resolution MIRAX MIDI system (Carl Zeiss). Images at 660
magnification were observed under the confocal microscope
FluoView FV1000 (Olympus).
Supporting Information
Figure S1 Immunoblotting results of the individual
mice. Lung protein extracts from three mice at 0, 7, 9 and
15 dpi were subjected to immunoblotting analysis with the
indicated antibodies.
(TIF)
Figure S2 Prdx6-positive nuclei are not observed in the
Pdpn (AT1cells)-negative inflamed area of alveoli.
Immunostained lung sections were scanned by MIRAX MIDI
system. A. A number of Prdx6-positive nuclei (in green) were
scattered in the normal alveoli. B. Prdx6-positive nuclei (arrows in
b, d, f, h) were not observed in Pdpn-negative inflamed area at
11 dpi (a, c, e). Bronchial Prdx6 started to express strongly at
11 dpi (a, c, e). The section was subsequently stained by H&E
staining (g, h). Cluster of five Prdx6-positive nuclei were circled
with dashed line. The scale bars represent 100 mm (a, c, e, g) and
50 mm (b, d, f, h), respectively.
(TIF)
Figure S3 Localization of Gpx3 in both uninfected and
infected mice lung. Mice were infected with sub-lethal dose of
PR8 by intra-tracheal inhalation. Immunostained lung sections
with the indicated antibodies and observed at660 magnification
with confocal microscope. The scale bars represent 50 mm. A.
Gpx3 was abundantly located at the basement membrane of blood
vessels (Bv) and bronchioles (Br) in the normal lung. Gpx3 was also
weakly detected at alveolus, but did not always appear at the
surface of AT2 cells that express higher Cat (white arrows in d, e,
f). B. Alveolar GPX3 at 7 dpi did not co-localized with AT1 cells
that express higher level of Prdx6 (thick arrows in a, b, c). Gpx3
was also strongly detected within some infiltrated cells (thin arrows
in a, b, c).
(TIF)
Table S1 Primary antibodies used in this study.
(DOC)
Table S2 Primers used for qRT-PCR in this study.
*Primer sequences were obtained from PrimerBank (http://pga.
mgh.harvard.edu/primerbank/index.html).
(DOC)
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